Back to search
Aspergillosis; Pulmonary, Invasive (Etiology)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Aspergillosis; Pulmonary, Invasive (Etiology) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Aspergillosis; Pulmonary, Invasive (Etiology) trials you may qualify forInvasive fungal infections (IFI) are a major concern for immunocompromised or vulnerable patients. Associated mortality is significant and depends on the timeli…
This is a Phase 2, multicenter study to evaluate APX001 for the treatment of invasive fungal infections caused by Aspergillus spp. or rare molds (eg, Scedospori…
The objective of this study is to deliver proof of concept that antifungal prophylaxis can reduce the incidence of Influenza Associated Aspergillosis (IAA) in I…